Ancora Advisors’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-8,385
Closed -$140K 923
2016
Q4
$140K Buy
+8,385
New +$140K 0.01% 605